Skip to content

Treatment of Myogenic Cranio Mandibular Dysfunction (CMD): a prospective randomised clinical trial, comparing a mechanical stretching device (TheraBite®) with standard physiotherapy

Treatment of Myogenic Cranio Mandibular Dysfunction (CMD): a prospective randomised clinical trial, comparing a mechanical stretching device (TheraBite®) with standard physiotherapy - treatment of CMD

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31080
Enrollment
100
Registered
2007-09-11
Start date
2007-07-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myogenic Cranio Mandibular Dysfunction

Interventions

None listed

Sponsors

Atos Medical
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with myogenic CMD 2. Patients with pain and/or a mouth opening of less than 35 mm 3. Signed informed consent

Exclusion criteria

Exclusion criteria: 1. Inability to understand the use of the TheraBite®/ standard exercises. 2. Physical disability (e.g. problem to manually use TheraBite®/ standard exercises). 3. Patients with non-myogenic underlying causes of limited mouth opening

Design outcomes

Primary

MeasureTime frame
Pain Maximum mouth opening

Secondary

MeasureTime frame
Perceived jaw function Quality of life

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)